IDEXX LABORATORIES INC /DE Accounts Receivable, Allowance for Credit Loss, Current
IDEXX LABORATORIES INC /DE (IDXX) had Accounts Receivable, Allowance for Credit Loss, Current of $11.30 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-02-20
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $11.30M.
- 2024-12-31: Accounts Receivable, Allowance for Credit Loss, Current $12.59M.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss, Current $9.50M.
- 2022-12-31: Accounts Receivable, Allowance for Credit Loss, Current $8.27M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2025-12-31 | $11.30M 10-K · filed 2026-02-20 |
| 2024-12-31 | $12.59M 10-K · filed 2026-02-20 |
| 2023-12-31 | $9.50M 10-K · filed 2025-02-21 |
| 2022-12-31 | $8.27M 10-K · filed 2024-02-22 |
| 2021-12-31 | $5.67M 10-K · filed 2023-02-16 |
| 2020-12-31 | $6.78M 10-K · filed 2022-02-16 |
| 2019-12-31 | $3.58M 10-K · filed 2021-02-12 |
| 2019-09-30 | $3.83M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $4.27M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $4.57M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $4.70M 10-K · filed 2020-02-14 |
| 2018-09-30 | $4.87M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $4.69M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $4.81M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $4.58M 10-K · filed 2019-02-15 |
| 2017-09-30 | $4.87M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $4.78M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $4.91M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $4.52M 10-K · filed 2018-02-16 |
| 2016-09-30 | $5.05M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $4.90M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $5.10M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $5.13M 10-K · filed 2017-02-17 |
| 2015-09-30 | $5.19M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $5.40M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $4.44M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $4.31M 10-K · filed 2016-02-17 |
| 2014-09-30 | $4.18M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $3.96M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $3.78M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $3.53M 10-K · filed 2015-02-17 |
| 2013-09-30 | $3.32M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $2.91M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $3.05M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $2.63M 10-K · filed 2014-02-18 |
| 2012-09-30 | $3.62M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $3.03M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $3.50M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $3.24M 10-K · filed 2013-02-19 |
| 2011-09-30 | $3.20M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $3.19M 10-Q · filed 2011-07-22 |
| 2011-03-31 | $3.36M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $2.83M 10-K · filed 2012-02-17 |
| 2010-09-30 | $3.09M 10-Q · filed 2010-10-22 |
| 2010-06-30 | $2.25M 10-Q · filed 2010-07-23 |
| 2009-12-31 | $2.33M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |